RAVULIZUMAB VERSUS ECULIZUMAB IN ADULTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: A PROSPECTIVE ANALYSIS ON THE DEEPNESS OF C5 INHIBITION BASED ON PHARMACOKINETICS/PHARMACODYNAMICS AND BREAKTHROUGH HEMOLYSIS OBSERVED IN TWO PHASE 3 RANDOMIZED, MULTICENTER STUDIES

A. M. Risitano, R. Peffault de Latour, S. T. Rottinghaus,P. Hillmen,S. Ortiz, J. Szer, H. Schrezenmeier, R. Aguzzi,A. Hill,J. W. Lee, A. G. Kulasekararaj,R. A. Brodsky

HAEMATOLOGICA(2019)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要